P. Mélin

1.1k total citations
20 papers, 335 citations indexed

About

P. Mélin is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, P. Mélin has authored 20 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in P. Mélin's work include Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (4 papers). P. Mélin is often cited by papers focused on Hepatitis C virus research (16 papers), Liver Disease Diagnosis and Treatment (12 papers) and Hepatitis B Virus Studies (4 papers). P. Mélin collaborates with scholars based in France, Germany and Switzerland. P. Mélin's co-authors include Denis Ouzan, P. Cacoub, Thierry Fontanges, Michel Rotily, M Chousterman, Patrick Marcellin, Marc Bourlière, Hervé Desmorat, Christophe Hézode and Jean‐Pierre Zarski and has published in prestigious journals such as Gastroenterology, Journal of Hepatology and World Journal of Gastroenterology.

In The Last Decade

P. Mélin

18 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Mélin France 8 315 282 65 21 15 20 335
Elizabeth Akoth United States 5 241 0.8× 218 0.8× 41 0.6× 6 0.3× 8 0.5× 10 257
Gebeyehu Teferi United States 2 276 0.9× 253 0.9× 39 0.6× 6 0.3× 8 0.5× 2 283
S. Gordon United States 9 213 0.7× 221 0.8× 59 0.9× 6 0.3× 16 1.1× 14 295
Karl‐Georg Simon Germany 11 519 1.6× 515 1.8× 85 1.3× 7 0.3× 13 0.9× 33 550
Peter Varunok United States 4 537 1.7× 484 1.7× 149 2.3× 13 0.6× 37 2.5× 4 557
Leonie Grellier United Kingdom 5 145 0.5× 132 0.5× 45 0.7× 12 0.6× 24 1.6× 6 189
Kerry Townsend United States 7 182 0.6× 128 0.5× 67 1.0× 14 0.7× 21 1.4× 11 214
Laveeza Bhatti United States 11 158 0.5× 127 0.5× 132 2.0× 9 0.4× 5 0.3× 20 276
V Thibaut France 4 230 0.7× 228 0.8× 45 0.7× 6 0.3× 7 0.5× 5 251
Alison Uriel United Kingdom 7 172 0.5× 150 0.5× 46 0.7× 3 0.1× 10 0.7× 10 211

Countries citing papers authored by P. Mélin

Since Specialization
Citations

This map shows the geographic impact of P. Mélin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Mélin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Mélin more than expected).

Fields of papers citing papers by P. Mélin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Mélin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Mélin. The network helps show where P. Mélin may publish in the future.

Co-authorship network of co-authors of P. Mélin

This figure shows the co-authorship network connecting the top 25 collaborators of P. Mélin. A scholar is included among the top collaborators of P. Mélin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Mélin. P. Mélin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marcellin, Patrick, M Chousterman, Thierry Fontanges, et al.. (2011). Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver International. 31(4). 516–524. 58 indexed citations
2.
Mélin, P., M Chousterman, Thierry Fontanges, et al.. (2010). Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice: results of a prospective cohort study. European Journal of Gastroenterology & Hepatology. 22(9). 1050–1057. 33 indexed citations
3.
Zarski, Jean‐Pierre, Nathalie Stürm, Hervé Desmorat, et al.. (2010). Non-invasive assessment of liver fibrosis progression in hepatitis C patients retreated for 96 weeks with antiviral therapy: a randomized study. Liver International. 30(7). 1049–1058. 11 indexed citations
4.
Mélin, P., Denis Ouzan, Michel Rotily, et al.. (2010). Pegylated Interferon-α2b plus Ribavirin Therapy in Patients with Hepatitis C and Psychiatric Disorders: Results of a Cohort Study. Antiviral Therapy. 15(4). 599–606. 14 indexed citations
5.
Michel, Laurent, et al.. (2009). Management of psychiatric disorders and addictive behaviors in patients with viral hepatitis C in France. Gastroentérologie Clinique et Biologique. 33(1). 1–7. 5 indexed citations
6.
7.
Zarski, Jean‐Pierre, Nathalie Stürm, Hervé Desmorat, et al.. (2008). 841 EFFICACY AND SAFETY OF 2 YEARS MAINTENANCE THERAPY WITH PEGINTERFERON ALPHA-2A IN CHRONIC HEPATITIS C: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (FIBROSYS). Journal of Hepatology. 48. S315–S316. 1 indexed citations
8.
Chossegros, P., P. Mélin, Christophe Hézode, et al.. (2008). A French prospective observational study of the treatment of chronic hepatitis C in drug abusers. Gastroentérologie Clinique et Biologique. 32(10). 850–857. 11 indexed citations
9.
Cacoub, P., Denis Ouzan, P. Mélin, et al.. (2008). Patient education improves adherence to peg-interferon and ribavirin in chronic genotype 2 or 3 hepatitis C virus infection: A prospective, real-life, observational study. World Journal of Gastroenterology. 14(40). 6195–6195. 29 indexed citations
10.
Moussalli, J., et al.. (2008). [Management of hepatitis C among drug user patients].. PubMed. 31(8-9 Pt 3). 4S51–5. 1 indexed citations
11.
12.
Agostini, Hélène, et al.. (2007). HEPACOM : multicenter, observational prospective study of outcome and monitoring of HCV positive antiviral-naïve patients managed in the French health care system. Gastroentérologie Clinique et Biologique. 31(12). 1074–1080. 5 indexed citations
13.
Moussalli, J., et al.. (2007). Prise en charge de l’hépatite C chez les patients utilisateurs de drogues. Gastroentérologie Clinique et Biologique. 31(8-9). 51–55. 3 indexed citations
14.
Bronowicki, Jean–Pierre, Denis Ouzan, Tarik Asselah, et al.. (2006). Effect of Ribavirin in Genotype 1 Patients With Hepatitis C Responding to Pegylated Interferon Alfa-2a Plus Ribavirin. Gastroenterology. 131(4). 1040–1048. 148 indexed citations
15.
Cacoub, P., Isabelle Goderel, Philippe Morlat, et al.. (2005). Management of chronic hepatitis C in French departments of internal medicine and infectious diseases. Epidemiology and Infection. 133(2). 305–314. 8 indexed citations
16.
Ouzan, Denis, Thierry Fontanges, P. Mélin, et al.. (2005). CA31 - Caractéristiques des malades inclus dans un observatoire prospectif et multicentrique sur l’observance du traitement de l’hépatite C (CHEOBS). Gastroentérologie Clinique et Biologique. 29(8-9). 915–915. 1 indexed citations
17.
Mélin, P., et al.. (2002). Quelles sont les attentes des malades atteints d'hépatite chronique C et comment y répondre?. Gastroentérologie Clinique et Biologique. 26. 291–296. 1 indexed citations
18.
Mélin, P., et al.. (2001). [About a case of chronic autoimmune thrombocytopenic purpura associated with toxoplasmosis].. PubMed. 59(4). 493–6. 2 indexed citations
19.
Delmée, Michel, et al.. (1995). Treatment ofClostridium DifficileColitis. Acta Clinica Belgica. 50(2). 114–116. 2 indexed citations
20.
Mélin, P., et al.. (1963). MALADIE D'URBACH-WIETHE FAMILIALE AVEC INDIFFERENCE 'A LA DOULEUR.. 19. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Elizabeth Akoth Breakdown of academic impact, for papers by Gebeyehu Teferi Breakdown of academic impact, for papers by S. Gordon Breakdown of academic impact, for papers by Karl‐Georg Simon Breakdown of academic impact, for papers by Peter Varunok Breakdown of academic impact, for papers by Leonie Grellier Breakdown of academic impact, for papers by Kerry Townsend Breakdown of academic impact, for papers by Laveeza Bhatti Breakdown of academic impact, for papers by V Thibaut Breakdown of academic impact, for papers by Alison Uriel
Rankless by CCL
2026